Beliefs and barriers to COVID-19 vaccination among older people with a history of stroke in Indonesia: a descriptive qualitative study

The COVID-19 vaccination program, aimed at vulnerable groups, such as elderly individuals with comorbidities such as stroke, has generated varied responses, including hesitancy due to internal health concerns and potential side effects. This study explored the experiences and perceptions of older adults with a history of stroke in Indonesia regarding the COVID-19 vaccina- tion program. This qualitative study employed a descriptive qual- itative approach using in-depth interviews. Participants were selected through purposive sampling, focusing on elderly individ- uals with metabolic conditions such as stroke. Data saturation was achieved with 23 participants, and the data were analyzed using Haase’s adaptation of the Colaizzi method. Several themes emerged, including rejection of the vaccination program, doubts and distrust of the COVID-19 vaccine, disbelief regarding vaccine content and benefits, concerns about stroke-related health risks, and feelings of compulsion or reluctance to participate in the pro- gram. The themes identified in this study provide insights into the barriers to COVID-19 vaccination in elderly individuals with a history of stroke. These findings could inform strategies for improving vaccination uptake in this vulnerable population.

Pang J, Wang MX, Ang IYH, et al. Potential rapid diagnostics, vaccine and therapeutics for 2019 novel coronavirus (2019-nCoV): A systematic review. J Clin Med 2020;9:623. DOI: https://doi.org/10.3390/jcm9030623

Polack FP, Thomas SJ, Kitchin N, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. New Engl J Med 2020;383:2603–15. DOI: https://doi.org/10.1056/NEJMoa2034577

Amit S, Regev-Yochay G, Afek A, et al. Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients. Lancet 2021;397:875–7. DOI: https://doi.org/10.1016/S0140-6736(21)00448-7

Dashraath P, Wong JLJ, Lim MXK, et al. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. Am J Obst Gynecol 2020;222:521–31. DOI: https://doi.org/10.1016/j.ajog.2020.03.021

Khalife J, VanGennep D. COVID-19 herd immunity in the absence of a vaccine: An irresponsible approach. Epidemiol Health 2021;43:e2021012. DOI: https://doi.org/10.4178/epih.e2021012

Lacsa JEM, Cordero DA. We are here...so where’s the vaccine? Achieving ‘herd immunity’ in the midst of the COVID-19 pandemic. J Public Health (United Kingdom) 2021;43:E533–4. DOI: https://doi.org/10.1093/pubmed/fdab195

Soegiarto G. Vaccination for coronavirus disease 2019: Opportunity, hope and chalenges. New Armenian Med J 2020;14:59–69.

Yousaf M, Afzaal M, DarAssi MH, et al. A mathematical model of vaccinations using new fractional order derivative. Vaccines 2022;10:1980. DOI: https://doi.org/10.3390/vaccines10121980

Efendi F, Dewi YS, Arifin H, et al. Policies and cultural beliefs: Community perceptions about COVID‐19 vaccine hesitancy in Indonesia. Public Health Nursing 2024;2019:736-44. DOI: https://doi.org/10.1111/phn.13318

Kumari A, Ranjan P, Chopra S, et al. What Indians think of the COVID-19 vaccine: A qualitative study comprising focus group discussions and thematic analysis. Diabetes Metab Syndr 2021;15:679–82. DOI: https://doi.org/10.1016/j.dsx.2021.03.021

Paulson KR, Kamath AM, Alam T, et al. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019. Lancet 2021;398:870–905. DOI: https://doi.org/10.1016/S0140-6736(21)01207-1

Efendi F. The intersection of the COVID-19 pandemic and population health. [La intersección de la pandemia de COVID-19 y la salud de la población.] Gaceta Medica de Caracas 2022;130:867–8.

Evandio. Sebanyak 40% lansia enggan divaksin, alasannya termasuk agama dan keamanan. Kabar24. 2021.

Kemenkes RI. Akselerasi Vaksinasi COVID-19 Jadi Kunci Tekan Angka Kematian Pada Lansia. Sehat Negeriku. 2021.

Sucipto. “46,6% Pasien Covid-19 Meninggal dari Kalangan Lansia”. medcom.id. 2021.

Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet 2020;395:470–3. DOI: https://doi.org/10.1016/S0140-6736(20)30185-9

Soegiarto G, Purnomosari D, Wulandari L, et al. Incidence of SARS-CoV-2 infection in hospital workers before and after vaccination programme in East Java, Indonesia – a retrospective cohort study. Lancet Reg Health - Southeast Asia 2023;10:100130. DOI: https://doi.org/10.1016/j.lansea.2022.100130

Bell S, Clarke R, Mounier-Jack S, et al. Parents’ and guardians’ views on the acceptability of a future COVID-19 vaccine: A multi-methods study in England. Vaccine 2020;38:7789–98. DOI: https://doi.org/10.1016/j.vaccine.2020.10.027

Wang J, Jing R, Lai X, et al. Acceptance of covid-19 vaccination during the covid-19 pandemic in china. Vaccines 2020;8:482. DOI: https://doi.org/10.3390/vaccines8030482

Latkin CA, Dayton L, Yi G, et al. Trust in a COVID-19 vaccine in the U.S.: A social-ecological perspective. Soc Sci Med 2021;270:113684. DOI: https://doi.org/10.1016/j.socscimed.2021.113684

Galanis P, Vraka I, Siskou O, Oet al. Predictors of COVID-19 vaccination uptake and reasons for decline of vaccination: a systematic review Running. Med Rxiv 2021; https://doi.org/10.1101/2021.07.28.21261261. DOI: https://doi.org/10.1101/2021.07.28.21261261

Subakti. Menkes Sebut Lansia Perlu Segera Divaksin, Ini Alasannya. cnbcindonesia. 2021.

Tanjung. Lansia dan Keluarganya Menolak Divaksin Covid-19, Pemkot Pekanbaru: Alasannya Mereka Tidak Pergi ke Mana-mana. Kompas.com. 2021.

Irwanto. Vaksinasi Lansia & Masyarakat Palembang Baru 50 Persen, Puskesmas Diminta Jemput Bola. merdeka.com. 2021.

Antara. Capaian Vaksinasi Lansia di Palembang Rendah, Ini yang Dilakukan Dinas Kesehatan. sumsel.inews.id. 2021.

Muir K-L, Kallam A, Koepsell SA, Gundabolu K. Thrombotic thrombocytopenia after Ad26.COV2.S vaccination. New Engl J Med 2021;384:1964–5. DOI: https://doi.org/10.1056/NEJMc2105869

Burhan E, Susanto AD, Nasution SA, et al. Buku Pedoman Tatalaksana Covid-19 & SOP. Burhan E, editor. Jakarta: Perhimpunan Dokter Paru Indonesia; 2020. 1–149 p.

Schulz JB, Berlit P, Diener HC, et al. COVID-19 Vaccine-Associated Cerebral Venous Thrombosis in Germany. Ann Neurol 2021;90:627–39. DOI: https://doi.org/10.1002/ana.26172

Ye W, Li Q, Yu S. Persuasive effects of message framing and narrative format on promoting covid-19 vaccination: A study on chinese college students. I Int J Environ Res Public Health 2021;18:9485. DOI: https://doi.org/10.3390/ijerph18189485

Gursoy D, Ekinci Y, Can AS, Murray JC. Effectiveness of message framing in changing COVID-19 vaccination intentions: Moderating role of travel desire. Tour Manag 2022;90:104468. DOI: https://doi.org/10.1016/j.tourman.2021.104468

Kreuter MW, McClure SM. The role of culture in health communication. Ann Rev Public Health 2004;25:439–55. DOI: https://doi.org/10.1146/annurev.publhealth.25.101802.123000

Knoblock J. Appendix A. COREQ (COnsolidated criteria for REporting Qualitative research) Checklist. J Australian Nurs Prof 2022;233–46.

Sargeant J. Qualitative research part II: participants, analysis, and quality assurance. J Grad Med Educ 2012;4:1–3. DOI: https://doi.org/10.4300/JGME-D-11-00307.1

Patton MQ. Nontraditional regulations, and innovations in darning-centered, doctoral education, including faculty meetings that are interesting and important, an indication of knovation of the highest order. Qualitative Inquiry 2002. 342 p.

Cresswell JW. Qualitative inquiry and research design. SAGE Publications; 2013.

Mesa Vieira C, Franco OH, Gómez Restrepo C, Abel T. COVID-19: The forgotten priorities of the pandemic. Maturitas 2020;136:38–41. DOI: https://doi.org/10.1016/j.maturitas.2020.04.004

Friedrich WN, Lysne M, Sim L, Shamos S. Assessing sexual behavior in high-risk adolescents with the Adolescent Clinical Sexual Behavior Inventory (ACSBI). Child Maltreatment 2004;9:239–50. DOI: https://doi.org/10.1177/1077559504266907

Gubernot D, Jazwa A, Niu M, et al. U.S. Population-Based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccines. Vaccine 2021;39:3666–77. DOI: https://doi.org/10.1016/j.vaccine.2021.05.016

Palmedo PC, Rauh L, Lathan HS, Ratzan SC. Exploring distrust in the wait and see: lessons for vaccine communication. American Behavioral Scientist 2021; https://doi.org/10.1177/00027642211062865 DOI: https://doi.org/10.1177/00027642211062865

Abu Aid O, Rohana H, Azrad M, Peretz A. Evaluation of vaccine perceptions in Israel’s Elderly: A Comparative study of COVID-19 and influenza vaccination attitudes. Vaccine: X 2024;20:100569. DOI: https://doi.org/10.1016/j.jvacx.2024.100569

Lazarus JV, Ratzan SC, Palayew A, et al. A global survey of potential acceptance of a COVID-19 vaccine. Nature Med 2020;27:225–8. DOI: https://doi.org/10.1038/s41591-020-1124-9

Rettenbacher MA, Hofer A, Ebenbichler C, et al. Prolactin levels and sexual adverse effects in patients with schizophrenia during antipsychotic treatment. J Clin Psychopharmacol 2010;30:711-5. DOI: https://doi.org/10.1097/JCP.0b013e3181faf0e3

Harapan H, Fathima R, Kusuma HI, et al. Drivers of and barriers to COVID-19 vaccine booster dose acceptance in Indonesia. Vaccines 2022;10:1981. DOI: https://doi.org/10.3390/vaccines10121981

Peng J, Marquez C, Rubio L, et al. High likelihood of accepting COVID-19 Vaccine in a Latinx community at high SARS-CoV-2 risk in San Francisco. Open Forum Infectious Diseases 2021;8:ofab202. DOI: https://doi.org/10.1093/ofid/ofab202

Hall VJ, Foulkes S, Charlett A, et al. SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN). Lancet 2021;397:1459–69. DOI: https://doi.org/10.1016/S0140-6736(21)00675-9

Supremo A, Bacason S, Sañosa AR. Sociodemographic correlates of older adult acceptance of the COVID-19 vaccine. Jurnal Ners 2022;17:2–7. DOI: https://doi.org/10.20473/jn.v17i1.29655

Schwarzinger M, Watson V, Arwidson P, et al. COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics. Lancet Public Health 2021;6:e210–21. DOI: https://doi.org/10.1016/S2468-2667(21)00012-8

Tambunan BA, Ugrasena DIG, Nugraha J, et al. Levels of SARS-COV-2 anti-spike protein receptor-binding domain (S-RBD) IgG in Indonesian-vaccinated healthcare workers: experimental research. Ann Med Surgery 2023;85:802–6. DOI: https://doi.org/10.1097/MS9.0000000000000425

Fitriah M, Permatasari CA, Nugraha J, et al. Quantitative neutralizing antibody using chemiluminescence assay for evaluating antibody response following inoculation of inactivated vaccine among healthcare workers in Surabaya, Indonesia. J Med Pharmaceut Chem Res 2024;6:1130–41.

Wang J, Yuan B, Lu X, et al. Willingness to accept COVID-19 vaccine among the elderly and the chronic disease population in China. Human Vaccines Immunother 2021;17:4873–88. DOI: https://doi.org/10.1080/21645515.2021.2009290

Khubchandani J, Sharma S, Price JH, et al. COVID-19 vaccination hesitancy in the United States: a rapid national assessment. J Comm Health 2021;46:270–7. DOI: https://doi.org/10.1007/s10900-020-00958-x

Jang SR, Lee SK, Connelly S. Understanding motivations and deterrents for COVID-19 vaccination among US working adults: A mixed method approach. Human Vaccines Immunother 2022;18:2132752. DOI: https://doi.org/10.1080/21645515.2022.2132752